Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice

17 May 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22610133
DOI: 10.1016/j.virusres.2012.05.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in micePMID 22610133Read ↗

Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity Read ↗

Chimeric alphavirus vaccine candidates for chikungunyaSemantic proximity Read ↗

Enhanced attenuation of chikungunya vaccines expressing antiviral cytokinesSemantic proximity Read ↗

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineSemantic proximity Read ↗

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseSemantic proximity Read ↗

Construction and immunogenicity of an mRNA vaccine against chikungunya virusSemantic proximity Read ↗

A Chimeric Vesiculo/Alphavirus Is an Effective Alphavirus VaccineSemantic proximity Read ↗

The Safety and Efficacy of the Chikungunya Virus Vaccine: A Systematic Review and Meta Analysis.Semantic proximity Read ↗

Chimeric Chikungunya Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but Efficiently Induce a Protective Immune ResponseSemantic proximity Read ↗

Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b studySemantic proximity Read ↗

Reverse vaccinology-based design of a universal multiepitope vaccine against chikungunya virus: phylogenetic and immunoinformatics approachesSemantic proximity Read ↗

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.